Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.9100 (3.2%) ($12.5350 - $12.9100) on Wed. Sep. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4% (three month average) | RSI | 42 | Latest Price | $12.9100(3.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) URA(31%) VT(31%) VUG(31%) XLK(31%) BLOK(29%) | Factors Impacting BCRX price | BCRX will decline at least -2% in a week (0% probabilities). VIXM(-14%) UUP(-13%) SMH(-12%) VXX(-3%) TLT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2% (StdDev 4%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.64(-64.06%) | Resistance Level | $13.25 | 5 Day Moving Average | $12.52(3.12%) | 10 Day Moving Average | $12.84(0.55%) | 20 Day Moving Average | $13.25(-2.57%) | To recent high | -12.9% | To recent low | 23.5% | Market Cap | $2.278b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |